This observation arises from the fact that the interaction between PAR-1 and thrombin activates the Ras, PKC, and MAPK pathways, leading to the proliferation of cancer cells and enhancing their ability to progress the disease (Xie et al., 2005). Here, MARK2 is linked to cancer.